Company News
Aesica recruits Business Development Manager
Aesica recruits Business Development Manager
Nadine Reuter will help drive sales in Germany, Austria and Switzerland
Intertek appoints Laboratory Director of Immunochemistry Centre of Excellence
Intertek appoints Laboratory Director of Immunochemistry Centre of Excellence
Dr Sarah Harris will lead the team in San Diego
C4X Discovery appoints Piers Morgan as Chief Executive
C4X Discovery appoints Piers Morgan as Chief Executive
Succeeds Sam Williams who returns to Non-Executive Director role
Solstice Biologics expands management team following achievement of technology milestones
Solstice Biologics expands management team following achievement of technology milestones
Appoints Lou Tartaglia as President and CEO, while John Borgeson joins as CFO
Robbie Stewart and Jen Doody join PCI UK team
Robbie Stewart and Jen Doody join PCI UK team
New appointments in Business Development and Human Resource Management
Oxford BioTherapeutics appoints Chief Scientific Officer
Oxford BioTherapeutics appoints Chief Scientific Officer
Dr Keith Wilson joins the company from AbbVie
ViroCyt strengthens management team
ViroCyt strengthens management team
Cellular and molecular immunologist joins the company as Chief Technology Officer
Spinifex Pharmaceuticals appoints neuroscience expert as Chief Medical Officer
Spinifex Pharmaceuticals appoints neuroscience expert as Chief Medical Officer
Ronald Marcus joins the Australian-US biotechnology company
Biovision announces the winners of the Catalyzer and Investor Conference awards
Biovision announces the winners of the Catalyzer and Investor Conference awards
This year’s focus was on finance and innovation
Biotec Services CEO joins Welsh government advisory panel
Biotec Services CEO joins Welsh government advisory panel
Aims to maximise the position of Wales in the global life sciences industry
Simon Angeldorff stays as CEO at Envirotainer
Simon Angeldorff stays as CEO at Envirotainer
Following a successful six months as interim CEO at the company
Martin Auster joins Ascendis Pharma as Chief Business Officer
Martin Auster joins Ascendis Pharma as Chief Business Officer
The company uses its TransCon technology to create drugs that address unmet medical needs
Seres Health appoints new President and CEO
Seres Health appoints new President and CEO
Roger Pomerantz was previously Head of Licensing & Acquisitions at Merck & Co
Celerion establishes an operation in Singapore
Celerion establishes an operation in Singapore
To be headed by Chew Lan Chong as Executive Director, Medical Research
Kymab makes two management appointments
Kymab makes two management appointments
Steve Arkinstall joins the company as Chief Scientific Officer and Nigel Clark as Head of Business Development
Dieter Weinand to become President of Bayer HealthCare Pharmaceuticals
Dieter Weinand to become President of Bayer HealthCare Pharmaceuticals
Will take up the role from 1 August
Bayer CEO Marijn Dekkers extends contract to the end of 2016
Bayer CEO Marijn Dekkers extends contract to the end of 2016
Werner Baumann appointed as Chief Strategy and Portfolio Officer and Johannes Dietsch to become Chief Financial Officer
Gensignia appoints CEO at US subsidiary
Gensignia appoints CEO at US subsidiary
Lee McCracken joins the company from Pathwork Diagnostics
New Sector Director role boosts offering to life sciences and manufacturing
New Sector Director role boosts offering to life sciences and manufacturing
Brendan Duigenan takes up a new role at Morgan Sindall Professional Services
Ivan Gergel becomes SVP, Drug Development & Chief Medical Officer at Nektar Therapeutics
Ivan Gergel becomes SVP, Drug Development & Chief Medical Officer at Nektar Therapeutics
Joins the company from Endo Pharmaceuticals
Gast Group appoints new President
Gast Group appoints new President
Kim Fields takes responsibility for Gast and Jun-Air brands
Andreas Fibig to leave Bayer HealthCare Pharmaceuticals
Andreas Fibig to leave Bayer HealthCare Pharmaceuticals
Will join International Flavors & Fragrances in New York on 1 September
Dr Sy Pretorius gains a promotion at Parexel
Dr Sy Pretorius gains a promotion at Parexel
Becomes Chief Scientific Officer and will continue to lead global Phase I and IIa services
Peter George joins Board of Ergomed as Non-Executive Director
Peter George joins Board of Ergomed as Non-Executive Director
He is currently Chief Executive of Clinigen